Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persephone: 6 vs 12 Months Trastuzumab in Early Breast Cancer
NCT00712140Phase 3Unknown
- Sponsor
- Warwick Medical School
- Start
- Oct 2007
- Primary completion
- Oct 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by Warwick Medical School. Status: unknown.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00712140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712140.